Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Allegheny Heart Institute, currently operating as the AHN Cardiovascular Institute, is a premier center for cardiac care, clinical research, and medical education based in Pittsburgh, Pennsylvania. As the flagship cardiovascular program of the Allegheny Health Network (AHN) and a subsidiary of Highmark Health, the institute provides a comprehensive range of services including advanced heart failure management, cardiothoracic surgery, and heart transplantation. It serves as a major clinical research hub, participating in over 100 national and international clinical trials to evaluate innovative medical devices and pharmacological treatments. The institute is particularly recognized for its expertise in structural heart interventions, such as transcatheter aortic valve replacement (TAVR), and advanced mechanical circulatory support. Through its affiliation with Drexel University College of Medicine, it also serves as a significant site for physician training and medical education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allegheny Heart Institute.